Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Obesity-induced extracellular vesicles proteins drive the endometrial cancer pathogenesis: therapeutic potential of HO-3867 and Metformin.
Sakaue T, Dorayappan KDP, Zingarelli R, Khadraoui W, Anbalagan M, Wallbillich J, Bognar B, Wanner R, Cosgrove C, Suarez A, Koga H, Maxwell GL, O'Malley DM, Cohn DE, Selvendiran K. Sakaue T, et al. Among authors: khadraoui w. Oncogene. 2024 Nov;43(49):3586-3597. doi: 10.1038/s41388-024-03182-2. Epub 2024 Oct 16. Oncogene. 2024. PMID: 39414985 Free PMC article.
ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasis.
Dorayappan KDP, Wagner V, Park D, Newcomer MM, Lightfoot MDS, Kalaiyarasan D, Sakaue T, Khadraoui W, Yu L, Wang QE, Maxwell GL, O'Malley D, Pollock RE, Cohn DE, Selvendiran K. Dorayappan KDP, et al. Among authors: khadraoui w. J Extracell Biol. 2024 Jan 31;3(2):e92. doi: 10.1002/jex2.92. eCollection 2024 Feb. J Extracell Biol. 2024. PMID: 38939897 Free PMC article.
Retraction notice to "Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer" [Gynecologic Oncology 183 (2024) 78-84].
Riedinger CJ, Barrington DA, Nagel CI, Khadraoui WK, Haight PJ, Tubbs C, Backes FJ, Cohn DE, O'Malley DM, Copeland LJ, Chambers LM. Riedinger CJ, et al. Among authors: khadraoui wk. Gynecol Oncol. 2024 Apr;183:R1. doi: 10.1016/j.ygyno.2024.04.024. Gynecol Oncol. 2024. PMID: 38839145 Free article. No abstract available.
RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer.
Riedinger CJ, Barrington DA, Nagel CI, Khadraoui WK, Haight PJ, Tubbs C, Backes FJ, Cohn DE, O'Malley DM, Copeland LJ, Chambers LM. Riedinger CJ, et al. Among authors: khadraoui wk. Gynecol Oncol. 2024 Apr;183:78-84. doi: 10.1016/j.ygyno.2024.03.020. Epub 2024 Mar 29. Gynecol Oncol. 2024. Retraction in: Gynecol Oncol. 2024 Apr;183:R1. doi: 10.1016/j.ygyno.2024.04.024 PMID: 38554477 Free article. Retracted.
Learning to lead: The evolution of a pilot leadership curriculum for gynecologic oncology fellows at the Ohio State University.
Levine MD, Wagner VM, Riedinger CJ, Khadraoui W, Haight PJ, Morton M, Barrington DA, Calo CA, Castaneda AV, Lightfoot M, Chalif J, Gonzalez A, Cohn DE. Levine MD, et al. Among authors: khadraoui w. Gynecol Oncol Rep. 2024 Jan 29;52:101327. doi: 10.1016/j.gore.2024.101327. eCollection 2024 Apr. Gynecol Oncol Rep. 2024. PMID: 38390623 Free PMC article. Review.
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer.
Haight PJ, Kistenfeger Q, Riedinger CJ, Khadraoui W, Backes FJ, Bixel KL, Copeland LJ, Cohn DE, Cosgrove CM, O'Malley DM, Nagel CI, Spakowicz DJ, Chambers LM. Haight PJ, et al. Among authors: khadraoui w. Gynecol Oncol. 2023 Nov;178:14-22. doi: 10.1016/j.ygyno.2023.09.005. Epub 2023 Sep 21. Gynecol Oncol. 2023. PMID: 37741201
18 results